Nolvadex Breast Cancer Prevention Registry Should Be Developed - Cmte.

FDA should work with Zeneca to develop a Nolvadex (tamoxifen) registry system to track healthy women who are taking the drug to reduce their risk of developing breast cancer, FDA's Oncologic Drugs Advisory Committee recommended Sept. 2.